FDA•
Niacin Extended-release Tablets
Lannett is recalling 1,000 mg Niacin Extended-release Tablets due to failed dissolution specifications.
Filters
Category
Agency
Severity
Drugs Recalls
Back to home ←
FDA•Xyvona (levorphanol tartrate) 2mg TabletsForte BioPharma is recalling Xyvona (levorphanol tartrate) 2mg tablets due to the FDA's denial of the product's proprietary name.
2 products
FDA•ToxiBan Charcoal-Kaolin SuspensionLloyd Inc. is recalling ToxiBan Charcoal-Kaolin Suspension due to microbial levels exceeding specification limits.